Active Research Studies
Thank you for your interest in our research studies! To see more information about the study you're interested in, please click on "More Info" located in each row.
Study Name |
Medication Involved |
Currently Enrolling |
|
---|---|---|---|
COllaborative, National QUality and Efficacy Registry for Tracking Disease Progression in Systemic Sclerosis (Scleroderma) Patients (CONQUER) |
NO | YES | MORE INFO |
Evaluating X-Chromosome Inactivation Maintenance in a Cross-sectional Cohort of Patients with Systemic Sclerosis | NO | YES | |
A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis (HORIZON) |
YES | NO | MORE INFO |
A Phase 2/3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab administered subcutaneously in adults with systemic sclerosis associated interstitial lung disease (BLISSc-ILD) | YES | YES | MORE INFO |
A Single Center Study of Patients with Autoimmune Diseases Receiving an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CARTIMMUNE) | YES | YES | MORE INFO |
SCTC White Paper Initiative | MORE INFO |